Overexpression of ADAM9 decreases radiosensitivity of hepatocellular carcinoma cell by activating autophagy

References

• Ferlay J, Soerjomataram I, Dikshit R, et al. Cancer incidence and mortality worldwide: sources, methods and major patterns in GLOBOCAN 2012. Int J Cancer. 2015;136:E359–386.
   PubMed Web of Science ®Google Scholar
• Dawson LA, Ten Haken RK. Partial volume tolerance of the liver to radiation. Semin Radiat Oncol. 2005;15:279–283.
   PubMed Web of Science ®Google Scholar
• Pan CC, Kavanagh BD, Dawson LA, et al. Radiation-associated liver injury. Int J Radiat Oncol Biol Phys. 2010;76:S94–S100.
   PubMed Web of Science ®Google Scholar
• Hong TS, Wo JY, Yeap BY, et al. Multi-institutional phase II study of high-dose hypofractionated proton beam therapy in patients with localized, unresectable hepatocellular carcinoma and intrahepatic cholangiocarcinoma. J Clin Oncol. 2016;34:460–468.
   PubMed Web of Science ®Google Scholar
• Kuang M, Xie XY, Huang C, et al. Long-term outcome of percutaneous ablation in very early-stage hepatocellular carcinoma. J Gastrointest Surg. 2011;15:2165–2171.
   PubMed Web of Science ®Google Scholar
• Shiina S, Tateishi R, Arano T, et al. Radiofrequency ablation for hepatocellular carcinoma: 10-year outcome and prognostic factors. Am J Gastroenterol. 2012;107:569–577; quiz 578.
   PubMed Web of Science ®Google Scholar
• Kudo M. Radiofrequency ablation for hepatocellular carcinoma: updated review in 2010. Oncology. 2010;78(Suppl 1):113–124.
   PubMedGoogle Scholar
• Arii S, Yamaoka Y, Futagawa S, et al. Results of surgical and nonsurgical treatment for small-sized hepatocellular carcinomas: a retrospective and nationwide survey in Japan. Liver Cancer Study Group of Jpn Hepatol. 2000;32:1224–1229.
   Google Scholar
• Abdel-Rahman O, Elsayed Z. External beam radiotherapy for unresectable hepatocellular carcinoma. Cochrane Database Syst Rev. 2017;3:Cd011314.
   PubMedGoogle Scholar
• Gerum S, Heinz C, Belka C, et al. Stereotactic body radiation therapy (SBRT) in patients with hepatocellular carcinoma and oligometastatic liver disease. Radiat Oncol. 2018;13:100.
   PubMed Web of Science ®Google Scholar
• Gkika E, Strouthos I, Kirste S, et al. Repeated SBRT for in- and out-of-field recurrences in the liver. Strahlentherapie und Onkologie. 2019;195:246–253.
   PubMed Web of Science ®Google Scholar
• Ursino S, Greco C, Cartei F, et al. Radiotherapy and hepatocellular carcinoma: update and review of the literature. Eur Rev Med Pharmacol Sci. 2012;16:1599–1604.
   PubMed Web of Science ®Google Scholar
• Kohga K, Takehara T, Tatsumi T, et al. Sorafenib inhibits the shedding of major histocompatibility complex class I-related chain A on hepatocellular carcinoma cells by down-regulating a disintegrin and metalloproteinase 9. Hepatology. 2010;51:1264–1273.
   PubMed Web of Science ®Google Scholar
• Tao K, Qian N, Tang Y, et al. Increased expression of a disintegrin and metalloprotease-9 in hepatocellular carcinoma: implications for tumor progression and prognosis. Jpn J Clin Oncol. 2010;40:645–651.
   PubMed Web of Science ®Google Scholar
• Dong Y, Shen X, He M, et al. Activation of the JNK-c-Jun pathway in response to irradiation facilitates Fas ligand secretion in hepatoma cells and increases hepatocyte injury. J Exp Clin Cancer Res. 2016;35:114.
   PubMed Web of Science ®Google Scholar
• Dong Y, Wu Z, He M, et al. ADAM9 mediates the interleukin-6-induced Epithelial-Mesenchymal transition and metastasis through ROS production in hepatoma cells. Cancer Lett. 2018;421:1–14.
   PubMed Web of Science ®Google Scholar
• Xin Y, Jiang F, Yang C, et al. Role of autophagy in regulating the radiosensitivity of tumor cells. J Cancer Res Clin Oncol. 2017;143:2147–2157.
   PubMed Web of Science ®Google Scholar
• Liu L, Liao JZ, He XX, et al. The role of autophagy in hepatocellular carcinoma: friend or foe. Oncotarget. 2017;8:57707–57722.
   PubMedGoogle Scholar
• Takahashi T, Shimizu K, Shimazaki K, et al. Environmental enrichment enhances autophagy signaling in the rat hippocampus. Brain Res. 2014;10:113–123.
   Google Scholar
• Xu HD, Qin ZH. Beclin 1, Bcl-2 and autophagy. Adv Exp Med Biol. 2019;12:109–126.
   Google Scholar
• Wang F, Tang J, Li P, et al. Chloroquine enhances the radiosensitivity of bladder cancer cells by inhibiting autophagy and activating apoptosis. Cell Physiol Biochem. 2018;45:54–66.
   PubMed Web of Science ®Google Scholar
• Huang T, Kim CK, Alvarez AA, et al. MST4 phosphorylation of ATG4B regulates autophagic activity, tumorigenicity, and radioresistance in glioblastoma. Cancer Cell. 2017;32:840–855.e848.
   PubMed Web of Science ®Google Scholar
• Oria VO, Lopatta P, Schilling O. The pleiotropic roles of ADAM9 in the biology of solid tumors. Cell Mol Life Sci. 2018;75:2291–2301.
   PubMed Web of Science ®Google Scholar
• Fritzsche FR, Wassermann K, Jung M, et al. ADAM9 is highly expressed in renal cell cancer and is associated with tumour progression. BMC Cancer. 2008;8:179.
   PubMed Web of Science ®Google Scholar
• Cooper C. Editorial comment on: ADAM9 expression is a significant and independent prognostic marker of PSA relapse in prostate cancer. Eur Urol. 2008;54:1107–1108.
   PubMed Web of Science ®Google Scholar
• Kim JM, Jeung HC, Rha SY, et al. The effect of disintegrin-metalloproteinase ADAM9 in gastric cancer progression. Mol Cancer Ther. 2014;13:3074–3085.
   PubMed Web of Science ®Google Scholar
• Hamada S, Satoh K, Fujibuchi W, et al. MiR-126 acts as a tumor suppressor in pancreatic cancer cells via the regulation of ADAM9. Mol Cancer Res.2012;10:3–10
   PubMed Web of Science ®Google Scholar
• Hua Y, Liang C, Miao C, et al. MicroRNA-126 inhibits proliferation and metastasis in prostate cancer via regulation of ADAM9. Oncol Lett. 2018;15:9051–9060.
   PubMed Web of Science ®Google Scholar
• Oria VO, Lopatta P, Schmitz T, et al. ADAM9 contributes to vascular invasion in pancreatic ductal adenocarcinoma. Mol Oncol. 2019;13:456–479.
   PubMed Web of Science ®Google Scholar
• Yang CX, Zhang SM, Li J, et al. MicroRNA-320 regulates the radiosensitivity of cervical cancer cells C33AR by targeting β-catenin. Oncol Lett. 2016;12:4983–4990.
   PubMed Web of Science ®Google Scholar
• Wan J, Hao L, Zheng X, et al. Circular RNA circ_0020123 promotes non-small cell lung cancer progression by acting as a ceRNA for miR-488-3p to regulate ADAM9 expression. Biochem Biophys Res Commun. 2019;515:303–309.
   PubMed Web of Science ®Google Scholar
• Liu Z, Liu W, Yu X, et al. C.J.E.r.f.m. Sun, p. sciences, Circ_0005276 aggravates the development of epithelial ovarian cancer by targeting ADAM9. Eur Rev Med Pharmacol Sci.2020;24: 10375–10382
   Google Scholar
• Xiang L, Ou H, Liu X, et al. Loss of tumor suppressor miR-126 contributes to the development of hepatitis B virus-related hepatocellular carcinoma metastasis through the upregulation of ADAM9.Tumour Biol. 2017;39:1–11
   Google Scholar
• Wan D, Shen S, Fu S, et al. miR-203 suppresses the proliferation and metastasis of hepatocellular carcinoma by targeting oncogene ADAM9 and oncogenic long non-coding RNA HULC. Anticancer Agents Med Chem.2016;16:414–423
   PubMed Web of Science ®Google Scholar
• Hu D, Shen D, Zhang M, et al. MiR-488 suppresses cell proliferation and invasion by targeting ADAM9 and lncRNA HULC in hepatocellular carcinoma. Am J Cancer Res. 2017;7:2070–2080
   PubMed Web of Science ®Google Scholar
• Arai J, Goto K, Stephanou A, et al. hepatology, Predominance of regorafenib over sorafenib: restoration of membrane-bound MICA in hepatocellular carcinoma cells.J Gastroenterol Hepatol. 2018;33:1075–1081
   PubMed Web of Science ®Google Scholar
• Zhu X, Wang Y, Tan L, et al. The pivotal role of DNA methylation in the radio-sensitivity of tumor radiotherapy. Cancer Med. 2018;7:3812–3819.
   PubMed Web of Science ®Google Scholar
• Cui L, Her S, Borst GR, et al. Radiosensitization by gold nanoparticles: will they ever make it to the clinic? Radiother Oncol. 2017;124:344–356.
   PubMed Web of Science ®Google Scholar
• Josson S, Anderson CS, Sung SY, et al. Inhibition of ADAM9 expression induces epithelial phenotypic alterations and sensitizes human prostate cancer cells to radiation and chemotherapy. Prostate. 2011;71:232–240.
   PubMed Web of Science ®Google Scholar
• Wang WJ, Long LM, Yang N, et al. NVP-BEZ235, a novel dual PI3K/mTOR inhibitor, enhances the radiosensitivity of human glioma stem cells in vitro. Acta Pharmacol Sin. 2013;34:681–690.
   PubMed Web of Science ®Google Scholar
• Mitrakas AG, Kalamida D, Giatromanolaki A, et al. Autophagic flux response and glioblastoma sensitivity to radiation. Cancer Biol Med. 2018;15:260–274.
   PubMed Web of Science ®Google Scholar
• Chen Y, Li X, Guo L, et al. Combining radiation with autophagy inhibition enhances suppression of tumor growth and angiogenesis in esophageal cancer. Mol Med Rep. 2015;12:1645–1652.
   PubMed Web of Science ®Google Scholar
• Shao CJ, Wu MW, Chen FR, et al. Histone deacetylase inhibitor, 2-propylpentanoic acid, increases the chemosensitivity and radiosensitivity of human glioma cell lines in vitro. Chin Med J (Engl). 2012;125:4338–4343.
   PubMed Web of Science ®Google Scholar
• Du HY, Wang R, Liang Li J, et al. Ligustrazine induces viability, suppresses apoptosis and autophagy of retinal ganglion cells with ischemia/reperfusion injury through the PI3K/Akt/mTOR signaling pathway. Bioengineered. 2021;12:507–515.
   PubMed Web of Science ®Google Scholar
• Bartolini D, Dallaglio K, Torquato P, et al. Nrf2-p62 autophagy pathway and its response to oxidative stress in hepatocellular carcinoma. Transl Res. 2018;193:54–71.
   PubMed Web of Science ®Google Scholar
• Katsuragi Y, Ichimura Y, Komatsu M. p62/SQSTM1 functions as a signaling hub and an autophagy adaptor. FEBS J. 2015;282:4672–4678.
   PubMed Web of Science ®Google Scholar
• Yang W, Sun T, Cao J, et al. Downregulation of miR-210 expression inhibits proliferation, induces apoptosis and enhances radiosensitivity in hypoxic human hepatoma cells in vitro. Exp Cell Res. 2012;318:944–954.
   PubMed Web of Science ®Google Scholar
• Xue M, Ge Y, Zhang J, et al. Anticancer properties and mechanisms of fucoidan on mouse breast cancer in vitro and in vivo. PloS One. 2012;7:e43483.
   PubMed Web of Science ®Google Scholar
• Srivastava M, Chen Z, Zhang H, et al. Replisome dynamics and their functional relevance upon DNA damage through the PCNA interactome. Cell Rep. 2018;25:3869–3883.e3864.
   PubMed Web of Science ®Google Scholar
• Li S, Shi D, Zhang L, et al. Oridonin enhances the radiosensitivity of lung cancer cells by upregulating Bax and downregulating Bcl-2. Exp Ther Med. 2018;16:4859–4864.
   PubMed Web of Science ®Google Scholar
• Assani G, Segbo J, Yu X, et al. Downregulation of TMPRSS4 enhances triple-negative breast cancer cell radiosensitivity through cell cycle and cell apoptosis process impairment. Asian Pac J Cancer Prev. 2019;20:3679–3687.
   PubMedGoogle Scholar
• Wang X, Polverino F, Rojas-Quintero J, et al. A disintegrin and a metalloproteinase-9 (ADAM9): a novel proteinase culprit with multifarious contributions to COPD. Am J Respir Crit Care Med. 2018;198:1500–1518.
   PubMed Web of Science ®Google Scholar